Angioedema Treatments
Find Angioedema Treatments
Medications for Angioedema
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Angioedema.
Found 15 Approved Drugs for Angioedema
Icatibant
Brand Names
Firazyr, Sajazir
Icatibant
Brand Names
Firazyr, Sajazir
Form: Injection
Method of administration: Subcutaneous
FDA approval date: August 25, 2011
Classification: Bradykinin B2 Receptor Antagonist
FIRAZYR ® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. FIRAZYR is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. ( 1 )
Danazol
Generic Name
Danazol
Danazol
Generic Name
Danazol
Form: Capsule
Method of administration: Oral
FDA approval date: August 09, 1996
Classification: Androgen
Endometriosis. Danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management. Hereditary Angioedema. Danazol capsules are indicated for the prevention of attacks of angioedema of all types (cutaneous, abdominal, laryngeal) in males and females.
Lisinopril
Brand Names
Qbrelis, Zestoretic, Zestril
Lisinopril
Brand Names
Qbrelis, Zestoretic, Zestril
Form: Tablet, Solution
Method of administration: Oral
FDA approval date: July 01, 2002
Classification: Angiotensin Converting Enzyme Inhibitor
QBRELIS is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older.
Kalbitor
Generic Name
Ecallantide
Kalbitor
Generic Name
Ecallantide
Form: Injection
Method of administration: Subcutaneous
FDA approval date: February 02, 2010
Classification: Plasma Kallikrein Inhibitor
KALBITOR ® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older. KALBITOR is a plasma kallikrein inhibitor indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older. ( 1 )
Enalapril
Brand Names
Epaned, Vaseretic, Vasotec
Enalapril
Brand Names
Epaned, Vaseretic, Vasotec
Form: Tablet, Solution
Method of administration: Oral
FDA approval date: December 24, 1985
Classification: Angiotensin Converting Enzyme Inhibitor
EPANED is an angiotensin-converting enzyme inhibitor indicated for: treatment of hypertension in adults and children older than one month, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
Showing 1-5 of 15
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances